Rockefeller Capital Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.6M Buy
463,079
+7,751
+2% +$379K 0.05% 352
2025
Q1
$23.2M Sell
455,328
-37,092
-8% -$1.89M 0.06% 316
2024
Q4
$22.2M Sell
492,420
-1,168
-0.2% -$52.7K 0.06% 319
2024
Q3
$18.3M Sell
493,588
-5,556
-1% -$206K 0.05% 367
2024
Q2
$15.3M Sell
499,144
-1,072
-0.2% -$32.8K 0.04% 394
2024
Q1
$14.6M Sell
500,216
-1,026
-0.2% -$29.8K 0.04% 408
2023
Q4
$13.8M Buy
501,242
+123,183
+33% +$3.39M 0.05% 374
2023
Q3
$8.47M Buy
378,059
+165,652
+78% +$3.71M 0.03% 464
2023
Q2
$8.64M Buy
212,407
+22,434
+12% +$912K 0.03% 473
2023
Q1
$9.2M Buy
189,973
+1,385
+0.7% +$67.1K 0.04% 432
2022
Q4
$7.2M Buy
188,588
+34,446
+22% +$1.31M 0.04% 449
2022
Q3
$7.74M Sell
154,142
-8,093
-5% -$406K 0.04% 424
2022
Q2
$6.5M Buy
162,235
+14,917
+10% +$598K 0.03% 449
2022
Q1
$5.5M Buy
147,318
+8,857
+6% +$330K 0.03% 527
2021
Q4
$5.51M Buy
138,461
+7,721
+6% +$307K 0.03% 515
2021
Q3
$4.86M Buy
130,740
+17,593
+16% +$655K 0.03% 491
2021
Q2
$4.78M Buy
+113,147
New +$4.78M 0.03% 463
2020
Q4
Sell
-2,787
Closed -$130K 2982
2020
Q3
$130K Hold
2,787
﹤0.01% 1173
2020
Q2
$141K Sell
2,787
-610
-18% -$30.9K ﹤0.01% 1054
2020
Q1
$152K Hold
3,397
﹤0.01% 888
2019
Q4
$163K Sell
3,397
-47
-1% -$2.26K ﹤0.01% 823
2019
Q3
$116K Sell
3,444
-96
-3% -$3.23K ﹤0.01% 757
2019
Q2
$159K Hold
3,540
﹤0.01% 614
2019
Q1
$133K Sell
3,540
-2,767
-44% -$104K ﹤0.01% 686
2018
Q4
$216K Hold
6,307
﹤0.01% 393
2018
Q3
$296K Buy
+6,307
New +$296K ﹤0.01% 315